title: [Evaluation of efficacy of hepatotropic drug legalon (the review of reports presented at the conference)].
abstract: Liver pathology, both of viral and non-viral etimology (alcoholic hepatitis, liver steatosis and etc.) is widely spread in Georgia. On such cases, diagnosis of disease and right strategy of treatment is very important, where hepatotropic drugs play an important role. A modern physician, infectionist-hepatologist or gastroenterologist, rely on evidence medicine. A 40 years experience of Legalon on the world market and recent research advantages of this multifunction. The above mentioned article gives a detailed description of significant role of medication in pathogenic treatment of liver diseases both of viral and non-viral etimology (alcoholic, toxic and etc.). Legalon becomes more interesting as the implementation process of its injection form is ongoing and necessity of application of the injection form is proved by the results of the newest international trials. The article depicts latest research presented at the special satellite conference that took place at the annual International Liver Congress by European Association for the Study of the Liver in 2011 (April-March) in Berlin.
authors.forename: M A
authors.initials: MA
authors.lastname: Kvitashvili
mesh_terms: D001604:Berlin; D002986:Clinical Trials as Topic; D005355:Fibrosis / Q000188:drug therapy; D006519:Hepatitis, Alcoholic / Q000188:drug therapy*; D006525:Hepatitis, Viral, Human / Q000188:drug therapy; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D012838:Silymarin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D012838:Silymarin